RNA-U4: A Potential Drug Target or Biomarker (G107048985)

Target Name: RNU4-46P

NCBI ID: G107048985

RNU4-46P

Other Name(s): RNA, U4 small nuclear 46, pseudogene

RNA-U4: A Potential Drug Target or Biomarker

RNA, U4 small nuclear 46, pseudogene (RNA-U4) is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. It is a small RNA molecule that is expressed in different cell types of the human body, including blood cells, epithelial cells, and muscle cells. RNA-U4 has been shown to play a role in various cellular processes, including cell signaling, DNA replication, and gene expression.

One of the unique features of RNA-U4 is its structure. It is a single molecule that is composed of four RNA bases: adenine (A), guanine (G), cytosine (C), and uracil (T). RNA-U4 has a characteristic stem-loop structure that is composed of a series of alternating A/G and C/T base pairs. This structure is similar to that of several other small RNA molecules, includinglet-184 and U6-283, which are also known as microRNAs.

RNA-U4 has been shown to play a role in various cellular processes in the human body. For example, studies have shown that RNA-U4 is involved in cell signaling, particularly in the regulation of cell proliferation. RNA-U4 has been shown to interact with several protein molecules, including the transcription factorp21 (TGF-β1). TGF-β1 is a well-known protein that is involved in the regulation of cell growth, differentiation, and apoptosis.

RNA-U4 has also been shown to play a role in gene expression. RNA-U4 has been shown to interact with the protein hnRNP A1, which is a component of the heterochromatin protein complex. hnRNP A1 is involved in the regulation of gene expression, and RNA-U4 has been shown to play a role in the regulation of hnRNP A1 activity.

In addition to its role in cellular signaling and gene expression, RNA-U4 has also been shown to have potential as a drug target or biomarker. One reason for its potential as a drug target is its unique structure, which allows it to interact with specific protein molecules in the human body. Additionally, RNA-U4 has been shown to play a role in the regulation of cellular processes that are often disrupted in diseases, such as cancer and neurodegenerative diseases. This suggests that RNA-U4 may be a useful target for the development of new therapeutic strategies.

RNA-U4 has also been shown to be a potential biomarker for several diseases. For example, studies have shown that RNA-U4 levels are often elevated in various types of cancer, including breast cancer and lung cancer. This suggests that RNA-U4 may be a useful biomarker for the diagnosis and prognosis of these diseases. Additionally, RNA-U4 has been shown to be elevated in the blood of individuals with neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. This suggests that RNA-U4 may be a useful biomarker for the diagnosis and prognosis of these diseases.

In conclusion, RNA-U4 is a unique and interesting molecule that has been shown to play a role in various cellular processes in the human body. Its characteristic stem-loop structure and its ability to interact with specific protein molecules make it a potential drug target or biomarker. Further research is needed to fully understand the role of RNA-U4 in cellular processes and its potential as a drug target or biomarker.

Protein Name: RNA, U4 Small Nuclear 46, Pseudogene

The "RNU4-46P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RNU4-46P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets